• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们衰老的方式及原因。

How and why we age.

作者信息

Hayflick L

机构信息

Department of Anatomy, University of California, San Francisco, School of Medicine, Sea Ranch 95497, USA.

出版信息

Exp Gerontol. 1998 Nov-Dec;33(7-8):639-53. doi: 10.1016/s0531-5565(98)00023-0.

DOI:10.1016/s0531-5565(98)00023-0
PMID:9951612
Abstract

After performing the miracles that takes us from conception to birth, and then to sexual maturation and adulthood, natural selection was unable to favor the development of a more elementary mechanism that would simply maintain those earlier miracles forever. The manifestations of this failure are called aging. Because few feral animals age, evolution could not have favored a genetic program for age changes. Natural selection favors animals that are most likely to become reproductively successful by developing better survival strategies and greater reserve capacity in vital systems to better escape predation, disease, accidents, and environmental extremes. Natural selection diminishes after reproductive success because the species will not benefit from members favored for greater longevity. The level of physiological reserve remaining after reproductive maturity determines longevity and evolves incidental to the selection process that acts on earlier developmental events. Physiological reserve does not renew at the same rate that it incurs losses because molecular disorder increases at a rate greater than the capacity for repair. These are age changes, and they increase vulnerability to predation, accidents, or disease. Failure to distinguish aging from disease has not only blurred our efforts to understand the fundamental biology of aging, but it has profound political and economic consequences that compromise the field of biogerontology. Changes attributable to disease, or pathological change, can be distinguished from age changes for at least four important reasons. Unlike any known disease, (1) age changes occur in every human given sufficient time, (2) age changes cross virtually all species barriers, (3) no disease afflicts all members of a species only after the age of reproductive success, and (4) aging occurs in all feral animals subsequently protected by humans, even when that species probably has not experienced aging for thousands or millions of years. The resolution of age-associated diseases will not advance our knowledge of aging, just as the resolution of the diseases of childhood did not advance our knowledge of childhood development. We have failed to convey that greater support must be given to a question that is rarely posed. It is a question that is applicable to all age-associated diseases, and its resolution will also advance our fundamental knowledge of aging: "Why are old cells more vulnerable to pathology and disease than are young cells?" During the first half of this century it was believed that because cultured normal cells were immortal, aging must be caused by extra-cellular events. Thirty-five years ago we overthrough this dogma when we found that normal cells do have a limited capacity to divide, and that age changes can occur intracellularly. We also observed that only abnormal or cancer cells are immortal. Normal cells are mortal because telomeres shorten at each division. Immortal cancer cells express the enzyme telomerase that prevents shortening. Recently, it was discovered that when the catalytic subunit of the telomerase gene is inserted into normal cells they become immortal.

摘要

在完成了从受孕到出生,再到性成熟和成年的种种奇迹之后,自然选择却无法促成一种更基本机制的发展,这种机制本可让那些早期的奇迹永远维持下去。这种失败的表现就被称为衰老。由于很少有野生动物会衰老,进化不可能青睐一种针对年龄变化的基因程序。自然选择青睐那些最有可能通过制定更好的生存策略以及在重要系统中拥有更强储备能力,从而更好地逃避捕食、疾病、事故和极端环境,进而在繁殖方面取得成功的动物。在繁殖成功之后,自然选择的作用就会减弱,因为物种不会从那些因寿命更长而受到青睐的个体中受益。生殖成熟后剩余的生理储备水平决定了寿命,并且是在作用于早期发育事件的选择过程中附带进化而来的。生理储备的损耗速度与更新速度不同,因为分子紊乱的增加速度超过了修复能力。这些就是年龄变化,它们会增加个体遭受捕食、事故或疾病的脆弱性。未能区分衰老和疾病,不仅模糊了我们对衰老基本生物学的理解,还产生了深远的政治和经济后果,损害了生物老年学领域。由于至少四个重要原因,可将归因于疾病的变化或病理变化与年龄变化区分开来。与任何已知疾病不同,(1)只要时间足够,年龄变化会发生在每个人身上;(2)年龄变化几乎跨越了所有物种障碍;(3)没有哪种疾病只在生殖成功年龄之后折磨一个物种的所有成员;(4)衰老发生在所有随后受到人类保护的野生动物身上,即使该物种可能已经数百万年没有经历过衰老了。解决与年龄相关的疾病并不会增进我们对衰老的认识,正如解决儿童疾病并没有增进我们对儿童发育的认识一样。我们未能传达出必须给予一个很少被提出的问题更多支持。这个问题适用于所有与年龄相关的疾病,其解决也将增进我们对衰老的基础知识:“为什么老细胞比年轻细胞更容易受到病理和疾病的影响?”在本世纪上半叶,人们认为由于培养的正常细胞是永生的,所以衰老一定是由细胞外事件引起的。35年前,我们推翻了这个教条,当时我们发现正常细胞确实具有有限的分裂能力,并且年龄变化可以在细胞内发生。我们还观察到只有异常细胞或癌细胞是永生的。正常细胞会死亡是因为端粒在每次分裂时都会缩短。永生的癌细胞表达端粒酶,这种酶可防止端粒缩短。最近,人们发现当将端粒酶基因的催化亚基插入正常细胞时,它们就会变成永生细胞。

相似文献

1
How and why we age.我们衰老的方式及原因。
Exp Gerontol. 1998 Nov-Dec;33(7-8):639-53. doi: 10.1016/s0531-5565(98)00023-0.
2
A brief history of the mortality and immortality of cultured cells.培养细胞的死亡与永生简史。
Keio J Med. 1998 Sep;47(3):174-82. doi: 10.2302/kjm.47.174.
3
Biological aging is no longer an unsolved problem.生物衰老不再是一个未解之谜。
Ann N Y Acad Sci. 2007 Apr;1100:1-13. doi: 10.1196/annals.1395.001.
4
Antecedents of cell aging research.细胞衰老研究的先驱。
Exp Gerontol. 1989;24(5-6):355-65. doi: 10.1016/0531-5565(89)90043-0.
5
Does aging need its own program, or is the program of development quite sufficient for it? Stationary cell cultures as a tool to search for anti-aging factors.衰老需要自身特定的程序吗?还是发育程序对衰老而言已足够?以静止细胞培养作为寻找抗衰老因子的工具。
Curr Aging Sci. 2013 Feb;6(1):14-20. doi: 10.2174/18746098112059990009.
6
Living forever and dying in the attempt.求长生而亡于途中。
Exp Gerontol. 2003 Nov-Dec;38(11-12):1231-41. doi: 10.1016/j.exger.2003.09.003.
7
Mortality and immortality at the cellular level. A review.
Biochemistry (Mosc). 1997 Nov;62(11):1180-90.
8
Telomere dynamics in adult hematological malignancies.成人血液系统恶性肿瘤中的端粒动力学
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Feb;163(1):1-7. doi: 10.5507/bp.2018.084. Epub 2019 Jan 10.
9
[A brief overview of the discovery of cell mortality and immortality and of its influence on concepts about aging and cancer].[细胞死亡与永生的发现及其对衰老和癌症概念影响的简要概述]
Pathol Biol (Paris). 1999 Dec;47(10):1094-104.
10
Telomere control of replicative lifespan.端粒对复制寿命的控制。
Exp Gerontol. 1997 Jul-Oct;32(4-5):375-82. doi: 10.1016/s0531-5565(96)00164-7.

引用本文的文献

1
NeuroD2 Modulates Hippocampal Neuronal Organization and Axon Guidance During Aging.NeuroD2在衰老过程中调节海马神经元组织和轴突导向
In Vivo. 2025 Jul-Aug;39(4):2050-2065. doi: 10.21873/invivo.14000.
2
Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.心力衰竭中的心脏中间代谢:底物利用、信号作用及治疗靶点。
Nat Rev Cardiol. 2025 Jun 22. doi: 10.1038/s41569-025-01166-7.
3
Establishment and characterization of the first immortalized vocal cord leukoplakia epithelial cell line.
首个永生化声带白斑上皮细胞系的建立与鉴定
Cancer Gene Ther. 2025 Jan;32(1):95-103. doi: 10.1038/s41417-024-00859-4. Epub 2024 Nov 23.
4
The evolution of ageing: classic theories and emerging ideas.衰老的演化:经典理论与新兴观点。
Biogerontology. 2024 Oct 29;26(1):6. doi: 10.1007/s10522-024-10143-5.
5
Pharmacology of Aging: as a Tool to Validate Drug Targets for Healthy Lifespan.衰老药理学:作为验证健康寿命药物靶点的工具
Aging Biol. 2024 Sep 13;2(1):20240034. doi: 10.59368/agingbio.20240034.
6
Decreasing Intracellular Entropy by Increasing Mitochondrial Efficiency and Reducing ROS Formation-The Effect on the Ageing Process and Age-Related Damage.通过提高线粒体效率和减少 ROS 形成来降低细胞内熵——对衰老过程和与年龄相关的损伤的影响。
Int J Mol Sci. 2024 Jun 7;25(12):6321. doi: 10.3390/ijms25126321.
7
Is Aging a Disease? A Critical Review Within the Framework of Ageism.衰老是一种疾病吗?在年龄歧视框架内的批判性综述。
Cureus. 2024 Feb 24;16(2):e54834. doi: 10.7759/cureus.54834. eCollection 2024 Feb.
8
Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention.细胞永生化:体内分子基础与体外获取技术
BioTech (Basel). 2023 Jan 28;12(1):14. doi: 10.3390/biotech12010014.
9
Nutritional requirements for the elderly in India: A status paper.印度老年人的营养需求:现状报告。
Indian J Med Res. 2022 Sep;156(3):411-420. doi: 10.4103/ijmr.ijmr_2784_21.
10
Biothermodynamics of Viruses from Absolute Zero (1950) to Virothermodynamics (2022).从绝对零度(1950 年)到病毒热动力学(2022 年)的病毒生物热力学
Vaccines (Basel). 2022 Dec 9;10(12):2112. doi: 10.3390/vaccines10122112.